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34Objective: In the cancer population, pericardial effusions are a common and potentially life-threatening occur-
rence. Although decompression benefits most patients, paradoxical hemodynamic instability (PHI) develops in
some, with hypotension and shock in the immediate postoperative period. This study examines paradoxical
hemodynamic instability after pericardial window and identifies prognostic factors in patients with cancer
who are treated for pericardial effusion.
Methods: Retrospective review of 179 consecutive pericardial windows performed for pericardial effusion in
a tertiary cancer center over a 5-year period (January 2004 through March 2009). Demographic, surgical, path-
ologic, and echocardiographic data were analyzed for the end points of paradoxical hemodynamic instability
(pressor-dependent hypotension requiring intensive care unit admission) and overall survival.
Results: The most common malignancies were lung (44%), breast (20%), hematologic (10%), and gastroin-
testinal (7%). Overall survival for the group was poor (median, 5 months); patients with hematologic malignant
disease fared significantly better than the others (median survival 36 months; P ¼ .008). Paradoxical hemody-
namic instability occurred in 19 (11%) patients. These patients were more likely to have evidence of tamponade
on echocardiogram (89% vs 56%; P ¼ .005), positive cytology/pathology (68% vs 41%; P ¼ .03), and higher
volume drained (674 mL vs 495 mL; P¼ .003). Overall survival was significantly shorter in those in whom par-
adoxical hemodynamic instability developed (median survival 35 vs 189 days; hazard ratio ¼ 3; P<.001), and
the majority of them (11/19, 58%) did not survive their hospitalization.
Conclusions: Postoperative hemodynamic instability after pericardial window portends a grave prognosis.
Evidence of tamponade, larger effusion volumes, and positive cytologic findings may predict a higher risk of
paradoxical hemodynamic instability and anticipate a need for invasive monitoring and intensive care postop-
eratively. (J Thorac Cardiovasc Surg 2011;141:34-8)Pericardial effusions are a common occurrence in patients
with cancer, often portending a poor prognosis. They can
arise secondary tometastatic involvement of the pericardium
but may also occur in the setting of inflammatory and infec-
tious conditions, heart failure, or as complications of cancer
treatment. Drainage of pericardial effusion may be indicated
for diagnosis, symptomatic relief, or release of cardiac tam-
ponade.Most patientswhoundergo evacuationof a clinically
significant pericardial effusion experience rapid improve-
ment in their symptoms and hemodynamic status.e Thoracic Service,a Department of Surgery, and the Cardiology Service,b De-
ent of Medicine, Memorial Sloan–Kettering Cancer Center, New York, NY.
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The Journal of Thoracic and Cardiovascular SurgeIn a subset of patients, however, drainage of a pericardial
effusion is paradoxically followed by worsening hemody-
namic compromise, as has been documented in several
case reports and series.1-11 This complication, referred to
by some authors as postoperative low cardiac output
syndrome, has been previously noted to occur in up to
5% of patients undergoing surgical drainage and is
associated with poor short-term survival.4,6,12 However,
other sizable series have not encountered patients with
hemodynamic instability after drainage, and some authors
have questioned the existence of this entity.7,13-16 When
reported, this phenomenon has been observed irrespective
of the drainage approach, having been noted in patients
undergoing subxiphoid pericardial window, window via
thoracotomy, and pericardiocentesis. This phenomenon
also appears to be independent of the underlying cause of
the effusion, occurring in patients with malignant,
infectious, and inflammatory effusions.
In this study, we corroborate the occurrence of paradox-
ical hemodynamic instability (PHI) in patients undergoing
drainage of pericardial effusions. The objectives of this
study were to identify patient characteristics associatedry c January 2011
Abbreviations and Acronyms
ICU ¼ intensive care unit
PHI ¼ paradoxical hemodynamic instability
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nostic factors, and to define the outcomes in patients with
cancer who are treated for pericardial effusion.
METHODS
We reviewed the case histories of all patients undergoing operative
drainage for pericardial effusions at Memorial Sloan–Kettering Cancer
Center consecutively over the 5-year period between January 2004 and
March 2009. All surgical pericardial windows were included, including
subxiphoid, thoracotomy, and thoracoscopic approaches. In general, open
subxiphoid windows performed with the patient under general anesthesia
were the preferred approach. Percutaneous approaches (pericardiocentesis)
were not captured in this surgical database and therefore were not included
in this analysis. Approval for this study was granted by the Institutional Re-
view Board of Memorial Sloan–Kettering Cancer Center in February 2009.
Patient characteristics were abstracted from medical records. Demo-
graphic data included age and gender. Pathologic data included the primary
diagnosis and the cytologic and pathologic analysis of the effusion and any
resected pericardium. Clinical data included the presence preoperatively of
atrial fibrillation or pulmonary embolism, volume of fluid drained, site of
primary malignant disease, and history of anthracycline exposure or
thoracic radiation.
The primary outcomes evaluated were the occurrence of PHI and overall
survival. PHI was defined as the development of unexpected vasopressor-
dependent hypotension in the immediate postoperative period requiring ad-
mission to the intensive care unit (ICU). We preferred this term over post-
operative low cardiac output syndrome, inasmuch as we had no specific
data on cardiac output. Patients who were in the ICU before the procedure,
receiving vasopressor support before decompression, or requiring ICU ad-
mission postoperatively for other reasons besides new-onset hypotension
(eg, inability to wean from mechanical ventilation) were not counted as
having PHI. Overall survival was measured from the date of procedure
to the date of death. If the date of death was unknown, patients were
censored at the date last known to be alive.
A total of 179 pericardial windows were performed, and 160 echocar-
diograms before drainage were available for review. All echocardiograms
before drainage in patients in whom PHI developed were reviewed by 2
board-certified echocardiographers (E.M. and W.S.). The presence of at
least a moderate-to-severe pericardial effusion (>1.5 cm) with tamponade
was confirmed by standard echocardiographic criteria: early diastolic right
ventricular collapse, early systolic right atrial collapse, greater than 25%
respiratory variation in the mitral inflow, and inferior vena cava plethora
with diminished respiratory variation. In the PHI group, with the exception
of 1 patient for whom care was withdrawn, all patients had postdrainage
echocardiograms performed within 3 days of drainage. These echocardio-
grams were reviewed for evidence of moderate-to-severe right ventricular
dilatation (right ventricular internal diameter in diastole greater than
3.7 cm), moderate-to-severe right ventricular dysfunction (visual assess-
ment), or moderate-to-severe left ventricular dysfunction (left ventricular
ejection fraction<40%). Postdrainage echocardiograms were performed
in 111 (69%) patients without PHI within 3 days of drainage. Those
with reports of right ventricular dysfunction, left ventricular dysfunction,
or right ventricular dilatation were reviewed to ensure that the echocardio-
graphic criteria were uniformly applied in the 2 groups.
Patient characteristics were compared using 2-sided t tests for contin-
uous variables and c2 or Fisher’s exact test for categorical variables.The Journal of Thoracic and CLog–rank tests were used for univariate analysis of survival. Multivariate
analysis was performed by the Cox proportional hazards method for
survival analysis and logistic regression was used for analysis of PHI. Ac-
tuarial survival was estimated using the Kaplan–Meier method. All statis-
tical analyses were performed using STATA/IC 10.0 software (STATA
Corporation, College Station, Tex).RESULTS
Over the course of the study, 179 pericardial windows
were performed in 174 patients. PHI developed in 19
(11%) patients. Baseline patient characteristics and clinical
variables are listed in Table 1. Patient age ranged from 1 to
86 years, with a median of 57.4 years, and did not signifi-
cantly differ in patients in whom PHI developed versus
those in whom it did not. Female gender predominated,
and gender proportion did not significantly differ between
the groups. A small fraction of patients had atrial fibrillation
or were found to have evidence of pulmonary embolism on
preoperative workup, but this did not differ significantly be-
tween the 2 groups. Approximately a quarter of the patients
had previous anthracycline chemotherapy and over a third
had prior thoracic radiotherapy, but neither exposure was
associated with PHI. The underlying sites of malignant dis-
ease are listed in Table 1, with lung and breast cancer rep-
resenting the largest proportion of cases. Patients with
sarcoma, gynecologic, pleural, and thymic malignant dis-
eases were included in the ‘‘Other’’ category. The site of
primary malignant disease was not associated with the
development of PHI.
Preoperative echocardiographic variables are listed in
Table 2. Echocardiographic evidence of tamponadewas sig-
nificantly associated with PHI, but no association of PHI
with preoperative left ventricular dysfunction was noted.
In the absence of echocardiographic evidence of tampo-
nade, PHI seldom occurred—PHI developed in only 4%
(3/72) of patients without tamponade compared with
a rate of 16% (16/103) among patients with tamponade
(P ¼ .02).
Surgical and pathologic variables analyzed included the
volume of pericardial fluid drained and the presence of ma-
lignant cells in the pericardial fluid or tissue (Table 1). The
mean volume of fluid drained was significantly higher
among patients in whom PHI developed. The finding of ma-
lignant cells on cytologic or pathologic analysis was signif-
icantly associated with the development of PHI.
Postoperative echocardiographic findings in patients with
PHI are summarized in Table 2. Of note, the majority of pa-
tients with PHI had normal biventricular function on echo-
cardiograms performed during the period of hemodynamic
compromise. The prevalence of right or left ventricular dys-
function was greater in patients with PHI, although this
trend did not meet statistical significance. A similar trend
toward an increased prevalence of right ventricular dilata-
tion in patients with PHI was observed.ardiovascular Surgery c Volume 141, Number 1 35
TABLE 1. Patient characteristics
PHI (n ¼ 19) No PHI (n ¼ 160) P
Age, mean  SD, y 54.0  13.8 55.8  15.3 .6
Gender
Male 6 (31.6%) 59 (36.9%) .8
Female 13 (68.4%) 101 (63.1%)
Primary malignant disease
Lung 8 (42.1%) 70 (43.8%) .9
Breast 5 (26.3%) 30 (18.8%)
Hematologic 2 (10.5%) 15 (9.4%)
Gastrointestinal 2 (10.5%) 11 (6.9%)
Other 2 (10.5%) 34 (21.2%)
Malignant cells identified,
cytology or pathology
13 (68.4%) 65 (40.6%) .03
Volume of pericardial fluid
drained, mean  SD, mL
674  217 495  231 .003
Preoperative atrial fibrillation 2 (10.5%) 9 (5.6%) .3
Concurrent pulmonary
embolism
2 (10.5%) 8 (5.0%) .3
Prior anthracycline exposure 5 (26.3%) 39 (24.4%) .8
Prior thoracic radiation 5 (26.3%) 65 (40.6%) .3
PHI, Paradoxical hemodynamic instability; SD, standard deviation.
TABLE 3. Multivariate analysis of factors associated with PHI
OR 95% CI P
Malignant cells identified,
cytology or pathology
5.8 1.2–28.3 .029
Volume of pericardial fluid
drained, per mL
1.003 1.0001–1.005 .043
Presence of tamponade 4.1 0.8–20.3 .082
PHI, Paradoxical hemodynamic instability; OR, odds ratio; CI, confidence interval.
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dial window is presented in Table 3. Factors independently
associated with PHI by logistic regression included malig-
nant effusion and volume of fluid drained, and the presence
of tamponade on echocardiogram approached statistical
significance after controlling for age, gender, and histologic
characteristics.
Most patients in whom PHI developed did not survive
their hospitalization, whereas the vast majority of patients
without PHI were discharged alive (in-hospital mortality,
58% vs 8%; P ¼ .0002). Overall survival (Figure 1, A)
was significantly worse in patients with PHI, with a median
survival of 35 days compared with 189 days for those with-
out PHI. PHI was associated with a 3-fold increased risk of
death by multivariate analysis. Independent predictors of
poor survival by multivariate analysis included PHI, preop-
erative atrial fibrillation, and malignant effusion, after con-
trolling for age and histologic type (Table 4). HematologicTABLE 2. Echocardiographic findings
PHI
(n ¼ 19)
No PHI
(n ¼ 160) P
Preoperative echocardiogram
Tamponade present 16/19 (84%) 87/155 (56%) .01
LV dysfunction, moderate-to-severe
(EF<40%)
0/19 (0%) 2/115 (2%) .7
Postoperative echocardiogram
LV dysfunction, moderate-to-severe
(EF<40%)
2/18 (11%) 3/90 (3%) .16
RV dysfunction, moderate-to-severe 4/17 (24%) 9/75 (12%) .25
RV dilatation, moderate-to-severe 2/18 (11%) 3/83 (4%) .22
PHI, Paradoxical hemodynamic instability; LV, left ventricular; EF, ejection fraction;
RV, right ventricular.
36 The Journal of Thoracic and Cardiovascular Surgemalignant disease demonstrated a trend toward improved
survival compared with solid tumors (Figure 1, B, Table 4).
DISCUSSION
This study investigated the management of pericardial
effusions in a cancer population, in which pericardial effu-
sions are a common occurrence. Paradoxically, unexpected
hemodynamic compromise develops in a subset of patients
after drainage, typically within the first few hours postoper-
atively. In this study, we found that PHI was a common
complication in our population, occurring in 11% of pa-
tients undergoing surgical drainage of a pericardial effu-
sion. The development of this phenomenon portended
a grave prognosis with a median survival of only 35 days.
The occurrence of PHI was a strong independent prognostic
factor for overall survival, and the majority of these patients
with PHI did not survive their hospitalization.
In our cohort, lung cancer and breast cancer were the
most frequent underlying malignant diseases, making up
nearly two thirds of the study population. The distribution
of primary malignant disease seen in our series is similar
to previously published reports.4,6,14,17 Survival was
similar in patients with lung, breast, and other solid
malignant tumors, with an overall median survival of 5
months. Patients with hematologic malignant disease
fared significantly better, with a median survival of 3
years. Poorer survival in patients with breast and lung
cancer having pericardial effusions reflected the advanced
stage of their disease, with over 90% of patients having
stage III or IV disease. In comparison, the majority
(70%) of patients with hematologic malignant disease
were initiating treatment or without evidence of disease,
and only 30% had advanced or refractory disease.
Hematologic malignant diseases were associated with
a trend toward decreased risk of death compared with
other malignant diseases (Table 4). The more favorable
prognosis for hematologic malignant diseases may support
a more aggressive stance toward the management of peri-
cardial effusions that present in these patients.
PHI was initially described in case reports, first by Van-
dyke and associates10 in 1983 and subsequently by Shenoy
and colleagues8 in 1984. In both cases, acute cardiogenic
pulmonary edema occurred after pericardial drainage in
patients with tamponade. These reports were followed by
similar independent descriptions over the ensuingry c January 2011
FIGURE 1. Patient survival curves. A, Overall survival of patients undergoing pericardial window with and without paradoxical hemodynamic instability
(PHI) (P<.001). B, Overall survival of patients undergoing pericardial window by cancer diagnosis (P ¼ .026). GI, Gastrointestinal.
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incidence of PHI was performed by Dosios and
associates,4 who termed this condition ‘‘postoperative low
cardiac output syndrome.’’ They described PHI in 5 patients
among 104 pericardial windows, 4 of whom died in the peri-
operative period, and established that PHI is a major predic-
tor of early mortality. Although earlier series describe large
cohorts in which no PHI occurred,14 ours is the fourth inde-
pendent series of pericardial windows to document this oc-
currence, with an incidence ranging from about 1% to 11%
in our cohort.4,12,17Wewould suggest PHI as a more precise
term for this occurrence, inasmuch as we found that
a majority of these patients have normal biventricular
function by echocardiographic criteria. We found a 3-fold
increased risk of death associated with PHI, with
mortality ensuing typically from the development of
multisystem organ failure.
This study is the first to examine systematically factors
that predict the development of PHI. Multivariate analysis
suggested that larger effusions and positive cytologic or
pathologic findings were independent predictors of PHI.
The presence of tamponade was also associated with
a greater risk of PHI that approached statistical significance;
PHI developed in the absence of tamponade in only 4% of
patients. Although cytologic results may not be immedi-
ately available intraoperatively, the finding of gross pericar-TABLE 4. Multivariate analysis of factors associated with overall
survival
HR 95% CI P
PHI 3.1 1.8–5.3 <.001
Preoperative atrial fibrillation 2.1 1.1–4.0 .025
Malignant cells identified,
cytology or pathology
1.9 1.3–2.8 .001
Hematologic malignancy 0.6 0.2–1.3 .166
PHI, Paradoxical hemodynamic instability;HR, hazard ratio; CI, confidence interval.
The Journal of Thoracic and Cdial involvement or a frozen section demonstrating
malignant disease may alert the surgeon to this risk factor.
Our data suggest that patients who have tamponade, a large
effusion, and evidence of malignant pericardial involve-
ment at the time of surgery may be at greater risk for PHI
and may anticipate a need for closer monitoring and inten-
sive care postoperatively.
Awareness of these risk factors may help to inform con-
versations with family members and consulting physicians
regarding the prognosis and the risks involved in this setting
when discussing management. The occurrence of PHI was
the strongest negative prognosticator of overall survival.
Once PHI occurs, the probability of recovery and successful
discharge from the hospital is relatively low, and acknowl-
edging these outcomes can help set expectations and guide
discussions regarding end-of-life care with family and
caregivers.
The causes of this phenomenon remain unclear. Some au-
thors have speculated that the acute decompression of tampo-
nade results in a sudden increase in preload overwhelming the
right ventricle, leading toventricular dilatation and right heart
failure.8 However, changes are not limited to the right side of
the heart, inasmuch as global ventricular failure has been ob-
served both in our series and in others.1,9,11 Others have
postulated that diminished coronary flow during tamponade
leads to myocardial hypoperfusion, resulting in impaired
contractility and systolic dysfunction that persists despite
the release of tamponade.11 Interestingly, an analogous pro-
cess has been described in up to 28% of patients undergoing
pericardiectomy in the setting of chronic constrictive pericar-
ditis, perhaps owing to myocardial atrophy.9,18 Although
atrial fibrillation was associated with overall survival in our
study, this is more likely a reflection of the hemodynamic
compromise of these patients, rather that its cause.
Although ventricular failure, right or left, was noted in
a subset of patients with PHI, the majority of patients with
PHI in the present study had normal biventricular functionardiovascular Surgery c Volume 141, Number 1 37
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instability. Further studies investigating the pathophysiology
of this process are clearly needed.
Questions remain regarding prevention of PHI and appro-
priate intervention once PHI occurs. In this study, all
patients underwent surgical decompression with the imme-
diate and total evacuation of effusion. In the pleural space,
the phenomenon of re-expansion pulmonary edema has
been described after drainage of large-volume pleural effu-
sions.19 It has been recommended that drainage of pleural
effusions be performed on a more gradual basis to prevent
this complication. It is unclear whether similar mechanisms
may be at work in the setting of pericardial effusions and
PHI. If so, then gradual drainage, for instance via percuta-
neous catheters, might reduce the risk of PHI and avoid
the risks of general anesthesia in hemodynamically com-
promised patients. Inasmuch as PHI rarely developed in pa-
tients without tamponade, consideration could also be given
to earlier prophylactic intervention for large asymptomatic
effusions. Prospective studies are needed to test and validate
these hypotheses. The onset of PHI occurred typically
within 24 to 48 hours after drainage, and the duration of
PHI was variable. Some patients recovered within 2 to 3
days, whereas others progressed to multiorgan system fail-
ure and death. Once PHI occurs, aggressive resuscitation
and hemodynamic support with vasopressors and inotropes
may salvage some of these patients, but expectations should
remain guarded.
Pericardial effusions continue to be a challenge in the
care of the patient with cancer. PHI is a devastating compli-
cation that occurs not infrequently and must be anticipated
when performing pericardial window in these patients.
Careful postoperative monitoring of these patients is indi-
cated, and further study is needed to understand the patho-
physiology and devise better strategies to prevent and
intervene in this poorly understood phenomenon.38 The Journal of Thoracic and Cardiovascular SurgeReferences
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